Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
WelbyTSE:4438 37 Days Payable is 55.28 as of Jun. 2026, which is 27% below its 10-year median of 75.30. GuruFocus rates TSE:4438 with a GF Score™ of 37/100 and a GF Value™ of 円457.43 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 613 Healthcare Providers & Services companies, Welby ranks worse than 50.41% on this metric.
Welby's average Accounts Payable for the
three
months ended in Jun. 2026 was 円47.0 Mil. Welby's Cost of Goods Sold for the
three
months ended in Jun. 2026 was 円77.7 Mil.
Hence, Welby's Days Payable for the
three
months ended in Jun. 2026 was 55.28.
The historical rank and industry rank for Welby's Days Payable or its related term are showing as below:
TSE:4438'
s Days Payable Range Over the Past 10 Years
Min: 56.46 Med: 75.3 Max: 114.93
Current: 56.84
During the past 10 years, Welby's highest Days Payable was 114.93. The lowest was 56.46. And the median was 75.30.
TSE:4438's Days Payable is ranked worse than 50.41% of 613
companies
in the Healthcare Providers & Services industry
Industry Median: 56.95
vs TSE:4438: 56.84
Welby's Days Payable
increased
from Jun. 2025 (42.42) to Jun. 2026 (55.28).
It may suggest that Welbydelayed paying its suppliers.
The historical data trend for Welby's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4438 vs VEEV, BTSG, HQY: Days Payable Comparison
For the Health Information Services subindustry, Welby's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Welby Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Welby's Days Payable distribution charts can be found below:
* The bar in red indicates where Welby's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Welby's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Welby (TSE:4438) has a Days Payable of 55.28 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Welby and its competitors. This is 27% below median its historical median of 75.30. Over the past decade, Welby's Days Payable has ranged from 56.46 to 114.93. According to the industry distribution chart, Welby ranks #309 out of 613 companies in the Healthcare Providers & Services industry, placing it in the top 50.4%.
Is Welby's Days Payable too high?
Welby's current Days Payable of 55.28 is 27% below median its 10-year median of 75.30. Over the past 10 years, this metric has ranged from a low of 56.46 to a high of 114.93. The Healthcare Providers & Services industry median Days Payable is 56.95. Welby's value of 55.28 is 2.9% below this industry median. Based on the distribution chart, Welby ranks #309 out of 613 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Welby has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Welby's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Welby ranks #309 out of 613 companies for Days Payable. This places Welby in the lower half of its industry. The industry median Days Payable is 56.95. Welby's value of 55.28 is 2.9% below this benchmark. Historically, Welby's own Days Payable has ranged from 56.46 to 114.93 over the past decade. While the company's 10-year median is 75.30 vs. the industry median of 56.95, Welby has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 56.95, based on 613 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Welby's current Days Payable of 55.28 is 2.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Welby and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 56.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Welby's current Days Payable is 55.28, which is 27% below median its own 10-year median of 75.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Welby stock overvalued right now?
Based on GuruFocus' analysis, Welby (TSE:4438) is currently considered Possible Value Trap. The stock's GF Value™ is 円457.43, compared to a current price of 円255.00 — trading 44.3% below its estimated fair value. The current Days Payable is 55.28, which is 27% below median its 10-year median of 75.30 and 2.9% below the Healthcare Providers & Services industry median of 56.95. Welby's overall GF Score™ is 37/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Welby (TSE:4438), the current Days Payable is 55.28 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Welby (TSE:4438) Overvalued in 2026?
Based on GuruFocus' analysis, Welby stock appears to be undervalued.
The current stock price of 円255.00 is trading 44.3% below its estimated GF Value™ of 円457.43.
GuruFocus considers Welby to be Possible Value Trap.
Key valuation signals for TSE:4438:
Days Payable: 55.28 (27% below median its 10-year median of 75.30)
GF Value™: 円457.43 vs. price of 円255.00 (44.3% below fair value)
Industry Position: 2.9% below the Healthcare Providers & Services median (#309 of 613)
No single metric tells the full story. See the TSE:4438 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Welby Inc offers patients and their families digital tools helping medical treatment and prevention of the progression of disease. The company co-develops and co-provides digital services with pharmaceuticals, medical device companies, governments, along with patients and healthcare professionals.
37GF Score
Get the complete analysis for TSE:4438
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4438 has been successfully added to your 
